110 related articles for article (PubMed ID: 19377281)
1. SIRT1/PARP-1 functional interplay.
Sassone-Corsi P
Cell Cycle; 2009 Jun; 8(11):1649. PubMed ID: 19377281
[No Abstract] [Full Text] [Related]
2. Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes.
Cantó C; Sauve AA; Bai P
Mol Aspects Med; 2013 Dec; 34(6):1168-201. PubMed ID: 23357756
[TBL] [Abstract][Full Text] [Related]
3. Cellular NAD depletion and decline of SIRT1 activity play critical roles in PARP-1-mediated acute epileptic neuronal death in vitro.
Wang S; Yang X; Lin Y; Qiu X; Li H; Zhao X; Cao L; Liu X; Pang Y; Wang X; Chi Z
Brain Res; 2013 Oct; 1535():14-23. PubMed ID: 23994215
[TBL] [Abstract][Full Text] [Related]
4. Contrasting sirtuin and poly(ADP-ribose)polymerase activities of selected 2,4,6-trisubstituted benzimidazoles.
Yeong KY; Tan SC; Mai CW; Leong CO; Chung FF; Lee YK; Chee CF; Abdul Rahman N
Chem Biol Drug Des; 2018 Jan; 91(1):213-219. PubMed ID: 28719017
[TBL] [Abstract][Full Text] [Related]
5. Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage.
Kolthur-Seetharam U; Dantzer F; McBurney MW; de Murcia G; Sassone-Corsi P
Cell Cycle; 2006 Apr; 5(8):873-7. PubMed ID: 16628003
[TBL] [Abstract][Full Text] [Related]
6. Functional interplay between Parp-1 and SirT1 in genome integrity and chromatin-based processes.
El Ramy R; Magroun N; Messadecq N; Gauthier LR; Boussin FD; Kolthur-Seetharam U; Schreiber V; McBurney MW; Sassone-Corsi P; Dantzer F
Cell Mol Life Sci; 2009 Oct; 66(19):3219-34. PubMed ID: 19672559
[TBL] [Abstract][Full Text] [Related]
7. SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1.
Rajamohan SB; Pillai VB; Gupta M; Sundaresan NR; Birukov KG; Samant S; Hottiger MO; Gupta MP
Mol Cell Biol; 2009 Aug; 29(15):4116-29. PubMed ID: 19470756
[TBL] [Abstract][Full Text] [Related]
8. PARP-1 inhibition does not restore oxidant-mediated reduction in SIRT1 activity.
Caito S; Hwang JW; Chung S; Yao H; Sundar IK; Rahman I
Biochem Biophys Res Commun; 2010 Feb; 392(3):264-70. PubMed ID: 20060806
[TBL] [Abstract][Full Text] [Related]
9. Weight Loss Is Associated With Increased NAD(+)/SIRT1 Expression But Reduced PARP Activity in White Adipose Tissue.
Rappou E; Jukarainen S; Rinnankoski-Tuikka R; Kaye S; Heinonen S; Hakkarainen A; Lundbom J; Lundbom N; Saunavaara V; Rissanen A; Virtanen KA; Pirinen E; Pietiläinen KH
J Clin Endocrinol Metab; 2016 Mar; 101(3):1263-73. PubMed ID: 26760174
[TBL] [Abstract][Full Text] [Related]
10. NAD
Saville KM; Clark J; Wilk A; Rogers GD; Andrews JF; Koczor CA; Sobol RW
DNA Repair (Amst); 2020 Sep; 93():102930. PubMed ID: 33087267
[TBL] [Abstract][Full Text] [Related]
11. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation.
Bai P; Cantó C; Oudart H; Brunyánszki A; Cen Y; Thomas C; Yamamoto H; Huber A; Kiss B; Houtkooper RH; Schoonjans K; Schreiber V; Sauve AA; Menissier-de Murcia J; Auwerx J
Cell Metab; 2011 Apr; 13(4):461-468. PubMed ID: 21459330
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy.
Pillai JB; Gupta M; Rajamohan SB; Lang R; Raman J; Gupta MP
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1545-53. PubMed ID: 16632544
[TBL] [Abstract][Full Text] [Related]
13. Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?
Zhang J
Bioessays; 2003 Aug; 25(8):808-14. PubMed ID: 12879452
[TBL] [Abstract][Full Text] [Related]
14. Progress in the function and regulation of ADP-Ribosylation.
Hottiger MO; Boothby M; Koch-Nolte F; Lüscher B; Martin NM; Plummer R; Wang ZQ; Ziegler M
Sci Signal; 2011 May; 4(174):mr5. PubMed ID: 21610250
[TBL] [Abstract][Full Text] [Related]
15. p53-, SIRT1-, and PARP-1-independent downregulation of p21WAF1 expression in nicotinamide-treated cells.
Lee HI; Jang SY; Kang HT; Hwang ES
Biochem Biophys Res Commun; 2008 Apr; 368(2):298-304. PubMed ID: 18230337
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue NAD
Jokinen R; Pirnes-Karhu S; Pietiläinen KH; Pirinen E
Redox Biol; 2017 Aug; 12():246-263. PubMed ID: 28279944
[TBL] [Abstract][Full Text] [Related]
17. NAD+ metabolism and NAD(+)-dependent enzymes: promising therapeutic targets for neurological diseases.
Ma Y; Chen H; He X; Nie H; Hong Y; Sheng C; Wang Q; Xia W; Ying W
Curr Drug Targets; 2012 Feb; 13(2):222-9. PubMed ID: 22204321
[TBL] [Abstract][Full Text] [Related]
18. Methods to Assess the Role of Poly(ADP-Ribose) Polymerases in Regulating Mitochondrial Oxidation.
Mikó E; Kovács T; Fodor T; Bai P
Methods Mol Biol; 2017; 1608():185-200. PubMed ID: 28695511
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 regulation of apoptosis of human chondrocytes.
Takayama K; Ishida K; Matsushita T; Fujita N; Hayashi S; Sasaki K; Tei K; Kubo S; Matsumoto T; Fujioka H; Kurosaka M; Kuroda R
Arthritis Rheum; 2009 Sep; 60(9):2731-40. PubMed ID: 19714620
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Poly(ADP-ribose) Polymerase-1 Enhances Gene Expression of Selected Sirtuins and APP Cleaving Enzymes in Amyloid Beta Cytotoxicity.
Wencel PL; Lukiw WJ; Strosznajder JB; Strosznajder RP
Mol Neurobiol; 2018 Jun; 55(6):4612-4623. PubMed ID: 28698968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
